Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infants
about
The epidemiology and diagnosis of invasive candidiasis among premature infantsDiuretic exposure in premature infants from 1997 to 2011Comparative effectiveness of digoxin and propranolol for supraventricular tachycardia in infants.Cefepime and Ceftazidime Safety in Hospitalized Infants.Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System DatabasePediatric post-marketing safety systems in North America: assessment of the current status.Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review.The Potential Role of Fosfomycin in Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.The safety and tolerability of the second-line injectable antituberculosis drugs in children.Neuropsychiatric Effects of Antimicrobial Agents.Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates.Drug use evaluation of Meropenem at a tertiary care university hospital: A report from Northern Iran.Leveraging Big Data in Pediatric Development Programs: Proceedings From the 2016 American College of Clinical Pharmacology Annual Meeting Symposium."Real-Time" High-Throughput Drug and Synergy Testing for Multidrug-Resistant Bacterial Infection: A Case Report
P2860
Q26861652-06DABFD7-D6A1-40DD-8483-C61D9929A7A6Q33415111-A7831D5B-8EAC-40F6-935E-BF39DDC27CABQ34458246-49372730-C9FD-4D08-8D12-FD91ABE4E535Q36069519-D078E7A8-7E08-438A-ACE1-074E888EC6EDQ37723303-005D0470-FAFF-47B6-9E16-8BEDB21781E4Q38534148-9616C740-6AC1-46EF-8E77-2E37652C5BE5Q38654209-C080F2D1-943A-4A21-9FCD-C4EFFAEFFA5BQ38689344-FC8B9035-08DC-4C60-9A7D-7641A0366A58Q38933875-BB9F1143-3DC9-4DE7-80C2-407775726E63Q39135986-87D9F277-46EB-4E06-AC11-912E38589718Q39492202-AEE8706D-4B2C-4CAB-AA13-CA46375E4C05Q41824157-72EFF019-11ED-40C3-B8BC-C04E69997465Q47741125-CC18946E-F06E-4A32-BFE0-9494D218828EQ57300149-5F46C25F-0E8D-49FE-82E8-70479B5C0A06
P2860
Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infants
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Adverse events associated with ...... cohort of hospitalized infants
@ast
Adverse events associated with ...... cohort of hospitalized infants
@en
Adverse events associated with ...... cohort of hospitalized infants
@nl
type
label
Adverse events associated with ...... cohort of hospitalized infants
@ast
Adverse events associated with ...... cohort of hospitalized infants
@en
Adverse events associated with ...... cohort of hospitalized infants
@nl
prefLabel
Adverse events associated with ...... cohort of hospitalized infants
@ast
Adverse events associated with ...... cohort of hospitalized infants
@en
Adverse events associated with ...... cohort of hospitalized infants
@nl
P2093
P2860
P1476
Adverse events associated with ...... cohort of hospitalized infants
@en
P2093
Amy H Herring
Christoph P Hornik
Daniel K Benjamin
Edmund V Capparelli
Gregory L Kearns
John van den Anker
Michael Cohen-Wolkowiez
P Brian Smith
P2860
P304
P356
10.1097/INF.0B013E31828BE70B
P407
P577
2013-07-01T00:00:00Z